مستشفى الملك فيصل التخصصي ومركز الأبحاث هو مستشفى تخصصي يقع في مدينة الرياض في المملكة العربية السعودية. يقدم المستشفى ومركز الأبحاث رعاية صحية أولية للمرضى المنومين والمُراجعين، ويشارك في العديد من الدراسات السريرية والبحثية.

During the past decade, King Faisal Specialist Hospital & Research Center conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 15 clinical trials were completed, i.e. on average, 24.2% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 10 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Faisal Specialist Hospital & Research Center" #1 sponsor was "King Faisal Specialist Hospital & Research Center" with 49 trials, followed by "Children's Oncology Group" with 10 trials sponsored, "Pfizer" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Faisal Specialist Hospital & Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Children's Hospital of Philadelphia" with 2 trials as a collaborator and "King Faisal Specialist Hospital & Research Center" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "King Faisal Specialist Hospital & Research Center" are "Breast Cancer" (6 trials), "COVID-19" (4 trials), "Critical Illness" (4 trials), "Vitamin D Deficiency" (4 trials) and "Hemophilia A" (3 trials). Many other conditions were trialed in "King Faisal Specialist Hospital & Research Center" in a lesser frequency.

Most popular intervention types in "King Faisal Specialist Hospital & Research Center" are "Drug" (70 trials), "Other" (37 trials), "Procedure" (18 trials), "Radiation" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Placebo" (9 trials), "Etoposide" (7 trials), "Cisplatin" (5 trials) and "Cyclophosphamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "King Faisal Specialist Hospital & Research Center" are 110 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "King Faisal Specialist Hospital & Research Center". undefined are not yet recruiting, 30 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in King Faisal Specialist Hospital & Research Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in King Faisal Specialist Hospital & Research Center, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 25 trials that are defined as “Not Applicable".

King Faisal Specialist Hospital & Research Center has several departments that took part in Clinical trials: "King Faisal Specialist Hospital & Research Centre; Oncology" - 6 trials